Evidence map›Paper›PMID 42007344›Full record

ArticleFrontiers in public health2026

Accelerometry and dual-scale neighborhood indicators for screening of MoCA-defined cognitive impairment: an interpretable machine-learning study.

Lei Zhang

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lei ZhangDepartment of Physical Education, Nanjing University of Chinese Medicine, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community-level identification of older adults who may benefit from confirmatory cognitive assessment is constrained by limited resources and the modest accuracy of single-domain screeners. Objective: This study aimed to develop and internally validate an interpretable prediction model for MoCA-defined cognitive impairment that integrates accelerometry with dual-scale (500 m and 800 m) built-environment indicators, and to evaluate calibration, clinical utility, and subgroup performance. The aim was to support community screening prioritization rather than etiologic inference or clinical diagnosis. Methods: We analyzed a cross-sectional sample of community-dwelling older adults from Nanjing, China ( Results: Tree-based models achieved the best overall performance. In the held-out test set, random forest showed high discrimination with acceptable calibration (AUC 0.95, 95% CI 0.91-1.00; Brier 0.088), while gradient boosting and support vector machine achieved AUCs approximately 0.90 with lower Brier scores for boosting (0.071). Decision curve analysis indicated a positive net benefit relative to the treat-all and treat-none strategies across clinically plausible risk thresholds. Explainability analyses consistently highlighted MVPA, sedentary time, age, central adiposity, and neighborhood transit accessibility as influential predictors. Subgroup analyses indicated broadly comparable discrimination, with small-to-moderate equalized-odds gaps. Conclusion: Combining accelerometry with neighborhood indicators may support calibrated, decision-oriented triage for MoCA-defined cognitive impairment in community settings. This model is intended for screening support rather than causal interpretation or diagnostic replacement, and requires external validation before implementation.

Indexed as

AccelerometryCognitive DysfunctionMachine LearningMass ScreeningNeighborhood CharacteristicsAgedChinaCross-Sectional StudiesFemaleHumansIndependent LivingMaleaccelerometrybuilt environmentcalibrationcognitive impairmentdecision-curve analysisneighborhood accessibilityolder adults

Identifiers

PMID42007344
PMCPMC13082955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.